Development of a continuous flow reactor for pharmaceuticals using catalytic monoliths: Pt/C selective oxidation of benzyl alcohol

F. Al Badran, S. Awdry, S.T. Kolaczkowski

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

A novel design of pilot-scale continuous flow pharmaceutical fixed-bed catalytic reactor has been developed. This incorporates in a structured manner the use of multiple catalytic monoliths (o.d. = 20 mm; L = 50 mm). O2 was used as the oxidant (O2/N2 mixture) for the partial oxidation of benzyl alcohol to benzaldehyde, using Pt impregnated (2.5 and 2.7 wt%) carbon monoliths. Reactions were performed e.g. at liquid flow = 1 dm 3 h-1; benzyl alcohol concentration = 1 kmol m -3; T = 110 C; P = 12 bar(g). A major breakthrough was the demonstration of the viability of this design at pilot-scale.
Original languageEnglish
Pages (from-to)229-239
Number of pages11
JournalCatalysis Today
Volume216
DOIs
Publication statusPublished - 1 Nov 2013

Fingerprint Dive into the research topics of 'Development of a continuous flow reactor for pharmaceuticals using catalytic monoliths: Pt/C selective oxidation of benzyl alcohol'. Together they form a unique fingerprint.

  • Cite this